The FDA approved lab-grown chicken for the first time, greenlighting products from startup Upside Foods for human consumption. If Upside gets USDA approval next, the company said it could start pumping out 50,000 pounds of “no-kill” meat products every year.
The news follows Upside’s April announcement that it had secured $400 million in Series C funding, moving the company “from R&D to commercialization,” according to CEO Uma Valeti.
“Our team...continues to overcome seemingly insurmountable challenges in our mission to make our favorite food a force for good,” said Valeti.
Upside, with 140 employees, has now garnered over $600 million in funding from names like Bill Gates and meat companies Tyson and Cargill.
Brian Sikes, Cargill COO, stresses his team’s commitment to meatless meat:
“Our continued support for UPSIDE’s innovative work underscores Cargill’s commitment to an inclusive approach to wholesome, sustainable protein that will meet customer and consumer needs now and in the future.”
Meanwhile, Beyond Meat announced it would lay off 19% of staff last month, and retail sales in the plant-based meat industry overall have dropped 10% in the past year.
More on lab-grown meat:
Beyond Meat Faces Lawsuit Over False Protein Content and Quality Claims
Hoxton Farms Raises $22 Million for Cultivated Animal Fat
